Non-small Cell Lung Cancer Stage IIIB/IV

1

Review clinical trials related to Non-small Cell Lung Cancer Stage IIIB/IV. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AK129 Combination Therapy for Advanced Solid Tumors

This is an open, multicenter phase Ib/II clinical study. The goal of this study is to confirm the Phase II recommended dose (RP2D) of AK129 combinations for advanced solid tumors and evaluate the safety and efficacy of AK129 combinations for non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), colorectal adenocarcinoma (CRC), and other advanced solid tumors.

Participants needed: 230
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: AkesoUpdated: Jun 3, 2025Locations: 1
Eligibility criteria

Be able and willing to provide written informed consent and to comply with all r... [+8]

Histologically or cytologically confirmed the presence of small cell carcinoma c... [+10]